Header cover image

U.S. Pharmaceuticals & Biotech Potential Buyback Winners

UPDATED Apr 29, 2024

Most likely to generate positive returns on buybacks.

30 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

KRON

Kronos Bio		US$1.004.2%-38.7%US$60.1mUS$4.25PS9.6xE7.5%n/a

SCYX

SCYNEXIS		US$1.8226.4%-41.3%US$58.2mUS$6.88PE1xE0.04%n/a

VBIV

VBI Vaccines		US$0.56-6.5%-80.6%US$16.3mUS$5.00PS1.8xE63.0%n/a

PTPI

Petros Pharmaceuticals		US$0.708.3%-83.7%US$4.4mUS$4.00PB0.4xE38.3%n/a

LADX

LadRx		US$2.5017.9%-69.8%US$1.2mn/aPE3.7xn/an/a

QBIO

Q BioMed		US$0.00020%-98.5%US$29.0kn/aPE-0.02xn/an/a
Page 2 of 2
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.